GLRA
GILD icon

Gerald L. Ray & Associates’s Gilead Sciences GILD Stock Holding History

Gerald L. Ray & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$6.59M Sell
81,292
-1,800
-2% -$138K 0.82% 28
2017
Q2 		$5.88M Buy
83,092
+8,067
+11% +$537K 0.76% 30
2017
Q1 		$5.1M Buy
75,025
+7,445
+11% +$524K 0.7% 35
2016
Q4 		$4.84M Sell
67,580
-900
-1% -$66.9K 0.7% 35
2016
Q3 		$5.42M Buy
68,480
+8,115
+13% +$659K 0.81% 31
2016
Q2 		$5.04M Buy
60,365
+450
+0.8% +$39.9K 0.8% 33
2016
Q1 		$5.5M Buy
59,915
+950
+2% +$85.7K 0.89% 30
2015
Q4 		$5.97M Buy
58,965
+1,550
+3% +$161K 0.94% 27
2015
Q3 		$5.64M Buy
57,415
+2,555
+5% +$284K 0.94% 26
2015
Q2 		$6.42M Buy
54,860
+380
+0.7% +$41.5K 0.98% 25
2015
Q1 		$5.35M Sell
54,480
-600
-1% -$60.9K 0.8% 33
2014
Q4 		$5.19M Sell
55,080
-2,110
-4% -$218K 0.8% 36
2014
Q3 		$6.09M Sell
57,190
-1,250
-2% -$122K 0.99% 30
2014
Q2 		$4.84M Buy
58,440
+940
+2% +$73.2K 0.83% 35
2014
Q1 		$4.07M Buy
57,500
+2,820
+5% +$221K 0.74% 39
2013
Q4 		$4.11M Sell
54,680
-440
-0.8% -$30.6K 0.77% 38
2013
Q3 		$3.46M Buy
55,120
+140
+0.3% +$8.37K 0.72% 41
2013
Q2 		$2.82M Buy
+54,980
New +$2.87M 0.63% 45

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerald L. Ray & Associates's GILD Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Gilead Sciences (GILD) stake by 2.2% in Q3 2017, selling an estimated $138K and leaving 81,292 shares worth $6.59M. The position accounts for 0.82% of the portfolio, ranked #28.

Gerald L. Ray & Associates first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Gerald L. Ray & Associates held 81,292 shares of Gilead Sciences worth $6.59M as of Q3 2017.
  • Gerald L. Ray & Associates sold 1,800 Gilead Sciences shares in Q3 2017, an estimated $138K.
  • Gilead Sciences made up 0.82% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #28 holding.
  • Gerald L. Ray & Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.